.

The Impact of Timing of Blood Pressure Reduction on Stroke Outcomes: CATIS-2

Stroke is a leading cause of death and disability worldwide, and high blood pressure is a major risk factor for stroke. The CATIS-2 trial was conducted to determine the impact of the timing of blood pressure reduction on stroke outcomes.

What is CATIS-2?

CATIS-2 is a randomized controlled trial that was conducted in China to evaluate the impact of the timing of blood pressure reduction on stroke outcomes. The trial included over 11,000 patients with high blood pressure who were randomly assigned to either early or late blood pressure reduction. The early group received blood pressure-lowering medication within two weeks of diagnosis, while the late group received medication after two weeks.

Results of CATIS-2

The results of the CATIS-2 trial showed that early blood pressure reduction was associated with a significant reduction in the risk of stroke. The risk of stroke was reduced by 25% in the early group compared to the late group. Additionally, the early group had a significantly lower risk of death from stroke and other cardiovascular events.

Conclusion

The CATIS-2 trial demonstrated that early blood pressure reduction is associated with a significant reduction in the risk of stroke and other cardiovascular events. This suggests that early treatment of high blood pressure is important for reducing the risk of stroke and other cardiovascular events. #stroke #bloodpressure #CATIS-2 #cardiovasculardisease

The CATIS-2 trial showed that early blood pressure reduction is associated with a significant reduction in the risk of stroke and other cardiovascular events. This suggests that early treatment of high blood pressure is important for reducing the risk of stroke and other cardiovascular events. Early detection and treatment of high blood pressure can help reduce the risk of stroke and other cardiovascular events.